AXT (AXTI) had the highest return between February 1, 2026 and March 31, 2026 by a US stock with a market cap of $2B+, returning 211.5%.
| ASSET | DATE | % RETURN |
|---|---|---|
AXT (AXTI) | 2/1/2026 - 3/31/2026 | 211.45% |
Applied Opt (AAOI) | 2/1/2026 - 3/31/2026 | 101.36% |
Nektar Therapeutics (NKTR) | 2/1/2026 - 3/31/2026 | 92.95% |
Sasol (SSL) | 2/1/2026 - 3/31/2026 | 88.65% |
Veradermics (MANE) | 2/1/2026 - 3/31/2026 | 85.74% |
Tango Therapeutics (TNGX) | 2/1/2026 - 3/31/2026 | 80.03% |
Valaris (VAL) | 2/1/2026 - 3/31/2026 | 75.38% |
Acadia Healthcare (ACHC) | 2/1/2026 - 3/31/2026 | 74.68% |
Lumentum (LITE) | 2/1/2026 - 3/31/2026 | 73.31% |
Par Pacific (PARR) | 2/1/2026 - 3/31/2026 | 72.56% |
LyondellBasell Industries (LYB) | 2/1/2026 - 3/31/2026 | 67.46% |
APA (APA) | 2/1/2026 - 3/31/2026 | 67.28% |
SM Energy (SM) | 2/1/2026 - 3/31/2026 | 67% |
Kodiak Sciences (KOD) | 2/1/2026 - 3/31/2026 | 65.31% |
SolarEdge Technologies (SEDG) | 2/1/2026 - 3/31/2026 | 64.73% |
Equinor ASA ADR (EQNR) | 2/1/2026 - 3/31/2026 | 64.28% |
Calumet Specialty Products Partners (CLMT) | 2/1/2026 - 3/31/2026 | 62.96% |
Delek US Energy (DK) | 2/1/2026 - 3/31/2026 | 59.54% |
Spyre Therapeutics (SYRE) | 2/1/2026 - 3/31/2026 | 58.82% |
Dianthus Therapeutics (DNTH) | 2/1/2026 - 3/31/2026 | 57.6% |
Palvella Therapeutics (PVLA) | 2/1/2026 - 3/31/2026 | 57.23% |
Ciena (CIEN) | 2/1/2026 - 3/31/2026 | 56.59% |
Pulse Biosciences (PLSE) | 2/1/2026 - 3/31/2026 | 56.56% |
DigitalOcean (DOCN) | 2/1/2026 - 3/31/2026 | 56.19% |
CVR Energy (CVI) | 2/1/2026 - 3/31/2026 | 55.76% |